Andrea E. Schwaninger

New cathinone‐derived designer drugs 3‐bromomethcathinone and 3‐fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC–MS and LC–high‐resolution MS and their detectability in urine

Markus R. Meyer, Christian Vollmar, Andrea E. Schwaninger et al. · Journal of Mass Spectrometry · 2012 · 91 citations

Medicine, Pharmacology, Toxicology +17

Convenient Gram-Scale Metabolite Synthesis by Engineered Fission Yeast Strains Expressing Functional Human P450 Systems

Călin-Aurel Drăgan, Frank T. Peters, Pierre Bour et al. · Applied Biochemistry and Biotechnology · 2010 · 63 citations

Life Sciences, Biochemistry, Biotechnology +12

Chiral drug analysis using mass spectrometric detection relevant to research and practice in clinical and forensic toxicology

Andrea E. Schwaninger, Markus R. Meyer, Hans H. Maurer · Journal of Chromatography A · 2012 · 62 citations

Pharmacy, Clinical Toxicology, Toxicology +16

Symptoms, toxicities, and analytical results for a patient after smoking herbs containing the novel synthetic cannabinoid MAM-2201

Adrian Derungs, Andrea E. Schwaninger, Gregory Mansella et al. · Forensic Toxicology · 2012 · 43 citations

Pharmacy, Pharmacology, Toxicology +13

Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography–linear ion trap–mass spectrometry (LC-MSn)

Markus R. Meyer, J. E. Dinger, Andrea E. Schwaninger et al. · Analytical and Bioanalytical Chemistry · 2011 · 41 citations

Pharmacy, Pharmacology, Toxicology +14